Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

The Central Bureau of Narcotics seized over 6.5 lakh tablets and injections of regulated drugs in Bijnor district, marking a significant crackdown on narcotic trafficking. The operation, based on intelligence, targeted psychotropic substances, leading to further investigations under the NDPS Act to dismantle the trafficking network.

The Central Bureau of Narcotics (CBN) has made a significant breakthrough in its ongoing fight against drug trafficking, officials announced Friday. A major haul of over 6.5 lakh tablets and injections of regulated substances was seized in Bijnor district.

The operation was executed on Thursday by CBN units from Bareilly and New Delhi, following specific intelligence alerts. Deputy Commissioner of Narcotics (Lucknow Zone), Praveen Bali, indicated that the confiscated drugs included psychotropic tablets such as alprazolam, chlordiazepoxide, tramadol, and tapentadol, along with injections of pentazocine and tramadol.

Authorities have filed a case under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, aiming to investigate the origin of the drugs and identify individuals and networks involved. This operation underscores CBN’s commitment to stifling the misuse and trafficking of controlled substances across India.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre